Korro Bio (KRRO) Retained Earnings (2018 - 2026)
Korro Bio (KRRO) posted Retained Earnings of $5000.0 for Q1 2026, up 100.0% on a QoQ basis from -$383.8 million in Q4 2025, and down 100.0% year-over-year from $428.7 million in Q1 2025.
Korro Bio (KRRO) Retained Earnings (2018 - 2026) Analysis & Trends
Korro Bio's Retained Earnings history runs 9 years deep, the most recent figure standing at $5000.0 for Q1 2026.
- Quarterly Retained Earnings fell 100.0% year-over-year to $5000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5000.0 (down 100.0% YoY) and the FY2025 annual result came in at -$383.8 million, down 189.95% from the prior year.
- Retained Earnings was $5000.0 for Q1 2026 at Korro Bio, up from -$383.8 million in the prior quarter.
- Across five years, Retained Earnings topped out at $428.7 million in Q1 2025 and bottomed at -$383.8 million in Q4 2025.
- A 5-year average of $25.5 million and a median of -$500.0 in 2023 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings soared 10887133.33% — and 2024, when it sank 3739900.0%.
- Korro Bio's Retained Earnings stood at -$101.8 million in 2022, then surged by 434.18% to $340.3 million in 2023, then advanced by 25.39% to $426.7 million in 2024, then tumbled by 189.95% to -$383.8 million in 2025, then soared by 100.0% to $5000.0 in 2026.
- Business Quant data shows KRRO's Retained Earnings at $5000.0 in Q1 2026, -$383.8 million in Q4 2025, and -$333.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -27.89 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -279.01 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 12.91 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -622,000.00 |
| 10 | Korro Bio | 123.70 Mn | 9.73 Mn | - | 5,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,000.00 |
| Dec 31, 2025 | -383.85 Mn |
| Sep 30, 2025 | -333.80 Mn |
| Jun 30, 2025 | 177,000.00 |
| Mar 31, 2025 | 428.66 Mn |
| Dec 31, 2024 | 426.72 Mn |
| Sep 30, 2024 | 574,000.00 |
| Jun 30, 2024 | -224.40 Mn |
| Mar 31, 2024 | -202.56 Mn |
| Sep 30, 2023 | 340.31 Mn |
| Jun 30, 2023 | -6,000.00 |
| Mar 31, 2023 | 334.49 Mn |
| Dec 31, 2022 | -101.83 Mn |
| Sep 30, 2022 | 326.62 Mn |
| Jun 30, 2022 | -392,000.00 |
| Mar 31, 2022 | -203.47 Mn |
| Dec 31, 2021 | -62,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Jun 30, 2021 | 7,000.00 |
| Mar 31, 2021 | 10,000.00 |